United States - English - NLM (National Library of Medicine)

dispensing solutions, inc. - latanoprost (unii: 6z5b6hvf6o) (latanoprost - unii:6z5b6hvf6o) - latanoprost 50 ug in 1 ml - xalatan sterile ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. known hypersensitivity to latanoprost, benzalkonium chloride or any other ingredients in this product.

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - latanoprost (unii: 6z5b6hvf6o) (latanoprost - unii:6z5b6hvf6o) - latanoprost 50 ug in 1 ml - xalatan is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. known hypersensitivity to latanoprost, benzalkonium chloride, or any other ingredients in this product. there are no adequate and well-controlled studies of xalatan administration in pregnant women.to inform drug-associated risks. in animal reproduction studies, intravenous (iv) administration of latanoprost to pregnant rabbits and rats throughout the period of organogenesis produced malformations, embryofetal lethality and spontaneous abortion at clinically relevant doses [see data] . the background risk of major birth defects and miscarriage for the indicated population is unknown. however, the background risk in the u.s. general population of major birth defects is 2 to 4%, and of miscarriage is 15 to 20% of clinically recognized pregnancies. embryofetal studies were conducted in pregnant rabbits administered latanoprost daily by iv injection on gestation days 6 through

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - latanoprost - eye drops, solution - latanoprost 50 mcg/ml - latanoprost - latanoprost - reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; water for injections; dibasic sodium phosphate - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are intolerant or insufficiently responsive to another intraocular pressure lowering medication. indications as at 4 february 2003: reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

tilia cordata) pollen 500micrograms/ml solution for skin prick test (inmunotek - linden (tilia cordata) pollen allergen extract - solution for skin-prick test

United States - English - NLM (National Library of Medicine)

washington homeopathic products - zincum oxydatum - to relieve the symptoms of debility. indications: zincum oxydatum debility if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - latanoprost -

New Zealand - English - Medsafe (Medicines Safety Authority)

upjohn new zealand ulc - latanoprost 50 µg/ml;  ;  ;   - eye drops, solution - 50 mcg/ml - active: latanoprost 50 µg/ml       excipient: benzalkonium chloride dibasic sodium phosphate monobasic sodium phosphate monohydrate sodium chloride water for injection - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Singapore - English - HSA (Health Sciences Authority)

viatris private limited - latanoprost - solution - 50 mcg/ml - latanoprost 50 mcg/ml

Canada - English - Health Canada

boiron laboratoires - baryta iodata - drops - 4ch - baryta iodata 4ch - homeopathic products